Legal & company information
Registered company details, regulatory status and important disclaimers for visitors, clinical partners and investors.
Last updated: 2026
1. Company details (Imprint)
This website is operated by Taugagreining - NerveDX ehf., trading as NerveDX.
- Legal name: Taugagreining - NerveDX ehf.
- Brand: NerveDX
- Kennitala (company ID): Available on request - contact info@nervedx.ai
- Registered office: Reykjavík, Iceland
- Email: info@nervedx.ai
- Website: https://nervedx.ai
Registered with the Icelandic Register of Enterprises (Firmaskrá).
2. Medical and regulatory disclaimer
NerveDX is a clinical software platform in active development. Content on this website is provided for general information and commercial discussion only. It does not constitute medical advice, a clinical recommendation, or an offer to supply a regulated medical device in any jurisdiction.
- Do not use this website to submit patient-identifiable information, EEG recordings, clinical reports, diagnoses or other protected health information.
- Product features, intended use, availability and deployment options vary by region, customer environment and regulatory status.
- Clinicians remain responsible for clinical judgment, review, confirmation and sign-off in any deployed workflow.
- Contact us for current product status, pilot availability and applicable regulatory boundaries before procurement or clinical use decisions.
3. Regulatory status
The table below describes our current public posture. Specific deployments are governed by contract, intended-use documentation and applicable local regulation.
| Topic | Current status |
|---|---|
| Intended use (summary) | Workflow support for long-duration clinical EEG review, navigation, governed AI-assisted triage, human confirmation, structured reporting, integration and audit - subject to formal intended-use and labeling documentation per deployment. |
| EU / MDR | Development aligned with medical device software expectations; formal conformity assessment, classification and market placement decisions are tracked through our quality system and updated as the product matures. |
| FDA (US) | Development informed by FDA expectations for clinical software |
| ISO 13485 | QMS-aligned development - formal certification status available on request |
| GDPR / privacy | Privacy-by-design orientation for website and platform development. See our Privacy Policy. |
| HIPAA | Deployment-specific - assessed per customer environment, controls and agreements |
For diligence, procurement or regulatory questions, contact info@nervedx.ai. Detailed architecture, validation and quality documentation may be shared under NDA where appropriate.
4. Website content disclaimer
We aim to keep this website accurate and current, but we make no warranty that all descriptions, roadmaps, performance statements or compliance references are complete or up to date at the time you read them. Features described may be planned, in pilot, or available only in specific environments.
5. Related policies
- Privacy Policy - how we handle personal data collected through this website
- Terms of Use - conditions for using this website
- Security & Compliance - product security and compliance posture
- Trust center - procurement, security and legal resources hub
- - manage optional cookies on this site
6. Contact
Legal, privacy and regulatory enquiries: info@nervedx.ai or our contact form.